242
Participants
Start Date
June 14, 2017
Primary Completion Date
March 17, 2021
Study Completion Date
March 17, 2021
Non-treatment, seroprevalence
Non-treatment study examining the prevalence of preexisting immunity to adeno-associated virus (AAV)
AKH - Medizinische Universität Wien, Vienna
Vivantes Klinikum im Friedrichshain, Berlin
Hôpital de la Timone, Marseille
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milan
Hospital Universitario La Paz, Madrid
Hospital Regional Universitario de Malaga, Málaga
Medical University of South Carolina (MUSC), Charleston
Hôpital Morvan, Brest
Presidio Ospedaliero di Castelfranco Veneto, Castelfranco Veneto
Ospedale San Bortolo di Vicenza, Vicenza
Hospital Universitario de Salamanca, Salamanca
CHU de Nantes Site Hotel Dieu, Nantes
Cincinnati Children's Hospital Medical Center, Cincinnati
Michigan State University, East Lansing
Azienda Ospedaliera Universitaria Careggi, Florence
Hopital Jeanne de Flandre - CHU Lille, Lille
Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt
Groupement Hospitalier Est- Hôpital Louis Pradel, Bron
Gulf States Hemophilia and Thrombophilia Center, Houston
University of Colorado Hemophilia & Thrombosis Center, Aurora
Orthopaedic Hemophilia Treatment Center, Los Angeles
Groupement Hospitalier Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre
University of Washington, Seattle
Baxalta now part of Shire
INDUSTRY